Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FKE17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,633
Award facts
- Contract value 100% obligated
- $71,632.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $71,632.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on September 29, 2025, with completion targeted for September 30, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award represents a non-set-aside, competitively awarded transaction typical of AmerisourceBergen's extensive pharmaceutical supply arrangements with the federal government. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent is a specialty pharmaceutical used in the treatment of eczema, asthma, and chronic rhinosinusitis, reflecting the scope of therapeutic medications supplied through the DLA Medical Supply Chain to support military and veteran healthcare systems. AmerisourceBergen's SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role as a critical vendor in federal medical procurement and its capability to fulfill federal requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FKE17?
SPE2DB25FKE17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE17 worth?
The government has obligated $71,633 on SPE2DB25FKE17.
Is contract SPE2DB25FKE17 an order under another contract?
Yes. SPE2DB25FKE17 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE17 competed?
The extent of competition for SPE2DB25FKE17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award